報價延遲最少15分鐘:2026/04/13 06:34 EDT
盤前時段
|
||||
|
-- 
|
|
|
常規時段 (已結束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.7
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.17/-0.50
|
|
企業價值
399.31M
|
| 資產負債 |
|
每股賬面淨值
0.66
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
77.27M
|
|
每股收益
0.82
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing dataand generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil. |
